Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Skin Cancer

Featured Content

Squamous Cell Carcinoma Resource Guide

FDA Approves Tecentriq in Combination with Cotellic and Zelboraf for Patients with Advanced Skin Cancer

Ryan McDonald

The Food and Drug Administration has approved Tecentriq in combination with Cotellic and Zelboraf for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

The Future of Melanoma Treatment May Be Complex, But 'Where There's a Will, There's a Way'

Jessica Skarzynski

Research in the melanoma space is finding itself facing complex challenges in implementing CAR-T cell therapy, but according to one expert these challenges are not insurmountable.

Investigating a Health Gap in Skin Cancer

Hannah Slater

CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma

Kristie L. Kahl

“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

Speaking Out: Taking Action Against Skin Cancer

By Beth Fand Incollingo and Kristie L. Kahl

Patients can pick from a growing array of treatments, from same-day- results surgery to game-changing immunotherapy, to fight the most common type of cancer.

FDA Approves Keytruda for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma

Ryan McDonald

The Food and Drug Administration approved Keytruda to treat patients with recurrent or metastatic cutaneous squamous cell carcinoma that cannot be treated with surgery or radiation.

Tafinlar and Mekinist Improve Long-Term Survival in Patients with BRAF Positive Melanoma

Jessica Skarzynski

“The relapse-free survival curves for both treatment arms appear to be reaching a plateau, which is a good sign if we are talking about cure,” said lead study author Dr. Axel Hauschild.

The Future of CSCC Management

Key opinion leaders close the discussion by considering the future of cutaneous squamous cell carcinoma (CSCC) and promising emerging regimens.

Multidisciplinary Management of CSCC

Experts in skin-care management discuss the role of the multidisciplinary team to provide patients with the best treatment strategy.

Immunotherapy in Patients Receiving Organ Transplantation

A discussion of the possibility of managing organ transplant populations with immunotherapy.

Skin Cancer

Sign In